AGN · Argenica Therapeutics Ltd
0.20
AUDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
AU$25.05M
PE
0.00
EV/EBITDA
N/A
DIV Yield
0%
Franking
0%
MQV Rating
5Very Weak
As at 27/08/2026 12:15:47 PM
Price Chart
Description
- All-Companies
- All-Consensus
- Big Candle
- GROWTH AUS
- HALO Consensus Value
- HALO Ords
- Hammer Bearish
Key Fundamentals
EPS 3 yr Growth
1.60%
EBITDA Margin
N/A
Operating Cashflow
-$6m
Free Cash Flow Return
-53.80%
ROIC
-67.70%
Interest Coverage
N/A
Quick Ratio
2.90
Performance
52 weeks range
Low 0.09 - 0.68
Trade Value (12mth)
AU$18,014.00
1 week
-9.52%
1 month
26.67%
YTD
-37.7%
1 year
-72.06%
All time high
1.02
Additional Data
Shares Outstanding (Fully Diluted)
128m
HALO Sector
Healthcare
Next Company Report Date
25-Aug-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Neutral
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
News & Announcements
| Date | Event |
26 August 26ASXD | |
26 August 26ASXD | |
13 August 26ASXD | |
27 July 26ASXD | |
24 July 26ASXD |
Key Stakeholders
| Name | Title |
| Neil Donald Delroy | Individual |
| Insignia Financial Ltd. | Holding Company |
| Liz Dallimore | Individual |
| Robert Hirzel Black | Individual |
